Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2014

Feb 27, 2014

30198_dirs_2014-02-27_cef21530-d63d-462f-87b5-92a84023b326.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-02-25

Reporting Person: TOPOL ERIC (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-25 Common Stock S 50000.0 $45.1714 Disposed 90909 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12207 Direct

Footnotes

F1: On December 30, 2013, Dr. Topol exercised 98,706 stock options granted to him on July 9, 2009. The 50,000 shares set forth above were sold to cover the tax liability which accrued upon the exercise of the 98,706 stock options.

F2: This transaction was executed in multiple trades at prices ranging from $45.00 to $45.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares.